4.7 Article

Independent comparison of Cog State computerized testing and a standard cognitive battery with neuroimaging

期刊

ALZHEIMERS & DEMENTIA
卷 10, 期 6, 页码 779-789

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2014.09.001

关键词

Preclinical Alzheimer's disease; Neuropsychology; Computerized cognitive battery; Neuroimaging; Amyloidbeta; Hippocampal volume

资金

  1. National Institutes of Health/National Institute [P50 AG016574, U01 AG006786, R01 AG041851, R01 AG011378]
  2. Robert H. and Clarice Smith and Abigail van Buren Alzheimer's Disease Research Program
  3. Driskill Foundation
  4. Rochester Epidemiology Project [R01 AG034676]
  5. NIH/NIA [P50 AG016574, U01 AG006786, R01 AG041851, R01 AG011378, U01 AG37526, R01 A0016574]
  6. Alzheimer Drug Discovery Foundation
  7. Michael J. Fox Foundation
  8. Alzheimer's Association
  9. NIH [U01 AG006786, R01 AG041851, R01 AG011378, R01 AG016574, R01 AG0113, P50 AG01657, R01 AG040042, P50 AG165741P1, P50 AG44170/P2]
  10. MN Partnership for Biotechnology and Medical Genomics
  11. Leukemia and Lymphoma Society
  12. Abbvie Health Economics and Outcomes Research
  13. National Institutes of Health [R01 AG041851, R01 AG011378, R01 AG037551, U01 HL096917, U01 AG032438, U01 AG024904]
  14. Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation

向作者/读者索取更多资源

Background: Inexpensive, non-invasive tools for assessing Alzheimer-type pathophysiologies are needed. Computerized cognitive assessments are prime candidates. Methods: Cognitively normal participants, aged 51-71, with magnetic resonance imaging, fluorodeoxyglucose-positron emission tomography (FDG-PET), amyloid PET, CogState computerized cognitive assessment, and standard neuropsychological tests were included. We first examined the association between the CogState battery and neuroimaging measures. We then compared that association to the one between standard neuropsychological z-scores and neuroimaging. Results: Slower reaction times for CogState Identification and One Back, and lower memory and attention z-scores, were associated (P < .05) with FDG-PET hypometabolism. Slower time on the Groton Maze Learning Task and worse One Card Learning accuracy were associated (P <.05) with smaller hippocampal volumes. There were no associations with amyloid PET. Associations of CogState and neuropsychological Z-scores with neuroimaging were small and of a similar magnitude. Conclusions: CogState subtests were cross-sectionally comparable to standard neuropsychological tests in their relatively weak associations with neurodegeneration imaging markers. (C) 2014 The Alzheimer's Association. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease

Jonathan Voeglein, Nicolai Franzmeier, John C. Morris, Marianne Dieterich, Eric McDade, Mikael Simons, Oliver Preische, Anna Hofmann, Jason Hassenstab, Tammie L. Benzinger, Anne Fagan, James M. Noble, Sarah B. Berman, Neill R. Graff-Radford, Bernardino Ghetti, Martin R. Farlow, Jasmeer P. Chhatwal, Stephen Salloway, Chengjie Xiong, Celeste M. Karch, Nigel Cairns, Richard J. Perrin, Gregory Day, Ralph Martins, Raquel Sanchez-Valle, Hiroshi Mori, Hiroyuki Shimada, Takeshi Ikeuchi, Kazushi Suzuki, Peter R. Schofield, Colin L. Masters, Alison Goate, Virginia Buckles, Nick C. Fox, Patricio Chrem, Ricardo Allegri, John M. Ringman, Igor Yakushev, Christoph Laske, Mathias Jucker, Gunter Hoglinger, Randall J. Bateman, Adrian Danek, Johannes Levin

Summary: Autosomal dominant Alzheimer's disease (ADAD) has distinct neurological examination findings that are useful for estimating prognosis and guiding clinical care and therapeutic trial designs.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Biomarker clustering in autosomal dominant Alzheimer's disease

Patrick H. Luckett, Charlie Chen, Brian A. Gordon, Julie Wisch, Sarah B. Berman, Jasmeer P. Chhatwal, Carlos Cruchaga, Anne M. Fagan, Martin R. Farlow, Nick C. Fox, Mathias Jucker, Johannes Levin, Colin L. Masters, Hiroshi Mori, James M. Noble, Stephen Salloway, Peter R. Schofield, Adam M. Brickman, William S. Brooks, David M. Cash, Michael J. Fulham, Bernardino Ghetti, Clifford R. Jack, Jonathan Voeglein, William E. Klunk, Robert Koeppe, Yi Su, Michael Weiner, Qing Wang, Daniel Marcus, Deborah Koudelis, Nelly Joseph-Mathurin, Lisa Cash, Russ Hornbeck, Chengjie Xiong, Richard J. Perrin, Celeste M. Karch, Jason Hassenstab, Eric McDade, John C. Morris, Tammie L. S. Benzinger, Randall J. Bateman, Beau M. Ances

Summary: This study analyzed 19 biomarkers of Alzheimer's disease using hierarchical clustering and feature selection, and found that amyloid and tau measures were the primary predictors. Emerging biomarkers of neuronal integrity and inflammation showed weaker predictive ability.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Association of neighborhood socioeconomic disadvantage and cognitive impairment

Maria Vassilaki, Jeremiah A. Aakre, Anna Castillo, Alanna M. Chamberlain, Patrick M. Wilson, Walter K. Kremers, Michelle M. Mielke, Yonas E. Geda, Mary M. Machulda, Rabe E. Alhurani, Jonathan Graff-Radford, Prashanthi Vemuri, Val J. Lowe, Clifford R. Jack, David S. Knopman, Ronald C. Petersen

Summary: The study found an association between neighborhood socioeconomic deprivation and cognitive decline, mild cognitive impairment, and dementia in older adults. Higher levels of neighborhood deprivation were associated with an increased risk of progression to dementia and slightly faster cognitive decline.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Traumatic brain injury and post-traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers

Michael W. Weiner, Danielle Harvey, Susan M. Landau, Dallas P. Veitch, Thomas C. Neylan, Jordan H. Grafman, Paul S. Aisen, Ronald C. Petersen, Clifford R. Jack, Duygu Tosun, Leslie M. Shaw, John Q. Trojanowski, Andrew J. Saykin, Jacqueline Hayes, Charles De Carli

Summary: The study found no significant association between TBI and/or PTSD and biomarker-defined AD. Veterans with TBI and/or PTSD had poorer cognitive status, which may be attributed to other comorbid pathologies.

ALZHEIMERS & DEMENTIA (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Change in Morphological Features of Enlarged Subarachnoid Spaces Following Treatment in Idiopathic Normal Pressure Hydrocephalus

Emanuele Camerucci, Jonathan Graff-Radford, David T. Jones, Benjamin D. Elder, Jeffrey L. Gunter, Jeremy K. Cutsforth-Gregory, Hugo Botha, Matthew C. Murphy, Derek R. Johnson, Caroline Davidge-Pitts, Clifford R. Jack, John Huston, Petrice M. Cogswell

Summary: This study evaluated the change in size of focally enlarged sulci (FES) and pituitary height after shunt placement in patients with idiopathic normal pressure hydrocephalus (iNPH). The results showed a significant decrease in FES volume and a significant increase in pituitary gland size after shunt placement.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Letter Clinical Neurology

Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study

Antoinette O'Connor, Emily Abel, Andrea Lessa Benedet, Teresa Poole, Nicholas Ashton, Philip Simon John Weston, Amanda J. Heslegrave, Natalie Ryan, Suzie Barker, James M. Polke, Kaj Blennow, Henrik Zetterberg, Nick C. Fox

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Letter Clinical Neurology

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study

Antoinette O'Connor, Helen Rice, Josephine Barnes, Natalie S. Ryan, Kathy Y. Liu, Ricardo Francisco Allegri, Sarah Berman, John M. Ringman, Carlos Cruchaga, Martin R. Farlow, Jason Hassenstab, Jae-Hong Lee, Richard J. Perrin, Chengjie Xiong, Brian Gordon, Allan Levey, Alison Goate, Neil Graff-Radford, Johannes Levin, Mathias Jucker, Tammie Benzinger, Eric McDade, Hiroshi Mori, James M. Noble, Peter R. Schofield, Ralph N. Martins, Stephen Salloway, Jasmeer Chhatwal, John C. Morris, Randall Bateman, Rob Howard, Suzanne Reeves, Nick C. Fox

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Biology

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study

Peter R. Millar, Brian A. Gordon, Patrick H. Luckett, Tammie L. S. Benzinger, Carlos Cruchaga, Anne M. Fagan, Jason J. Hassenstab, Richard J. Perrin, Suzanne E. Schindler, Ricardo F. Allegri, Gregory S. Day, Martin R. Farlow, Hiroshi Mori, Georg Nuebling, Randall J. Bateman, John C. Morris, Beau M. Ances

Summary: Estimates of 'brain-predicted age' quantify apparent brain age compared to normative trajectories of neuroimaging features. The brain age gap (BAG) between predicted and chronological age is elevated in symptomatic Alzheimer disease (AD) but has not been well explored in presymptomatic AD. Prior studies have typically modeled BAG with structural MRI, but more recently other modalities, including functional connectivity (FC) and multimodal MRI, have been explored.
Article Clinical Neurology

Predicting amyloid PET and tau PET stages with plasma biomarkers

Clifford R. Jack Jr, Heather J. Wiste, Alicia Algeciras-Schimnich, Dan J. Figdore, Christopher G. Schwarz, Val J. Lowe, Vijay K. Ramanan, Prashanthi Vemuri, Michelle M. Mielke, David S. Knopman, Jonathan Graff-Radford, Bradley F. Boeve, Kejal Kantarci, Petrice M. Cogswell, Matthew L. Senjem, Jeffrey L. Gunter, Terry M. Therneau, Ronald C. Petersen

Summary: Staging the severity of Alzheimer's disease pathology is important for therapeutic trials and clinical prognosis. Biomarkers such as amyloid and tau PET can be used for disease staging, but plasma biomarkers would be more practical.
Article Clinical Neurology

Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [18F]flortaucipir study

Antoinette O'Connor, David M. Cash, Teresa Poole, Pawel J. Markiewicz, Maggie R. Fraser, Ian B. Malone, Jieqing Jiao, Philip S. J. Weston, Shaney Flores, Russ Hornbeck, Eric McDade, Michael Schoell, Brian A. Gordon, Randall J. Bateman, Tammie L. S. Benzinger, Nick C. Fox

Summary: Cortical tau accumulation is a crucial pathological event in Alzheimer's disease, and understanding the timing and pattern of tau deposition can help track the disease progression. This study used data from participants in AD cohort studies to investigate if tau PET can detect early changes in presymptomatic carriers and found that there were regional differences in tau accumulation prior to symptom onset, particularly in posterior regions.

ALZHEIMERS RESEARCH & THERAPY (2023)

Article Clinical Neurology

Altered within- and between-network functional connectivity in atypical Alzheimer's disease

Neha Atulkumar Singh, Peter R. Martin, Jonathan Graff-Radford, Irene Sintini, Mary M. Machulda, Joseph R. Duffy, Jeffrey L. Gunter, Hugo Botha, David T. Jones, Val J. Lowe, Clifford R. JackJr, Keith A. Josephs, Jennifer L. Whitwell

Summary: Posterior cortical atrophy and logopenic progressive aphasia are atypical clinical presentations of Alzheimer's disease, both showing disruptions in functional networks. The language network is affected in logopenic progressive aphasia, while the visual network is affected in posterior cortical atrophy. However, there is limited knowledge about the differences in connectivity within and between brain networks in these atypical Alzheimer's disease phenotypes.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Default mode network failure and neurodegeneration across aging and amnestic and dysexecutive Alzheimer's disease

Nick Corriveau-Lecavalier, Jeffrey L. Gunter, Michael Kamykowski, Ellen Dicks, Hugo Botha, Walter K. Kremers, Jonathan Graff-Radford, Daniela A. Wiepert, Christopher G. Schwarz, Essa Yacoub, David S. Knopman, Bradley F. Boeve, Kamil Ugurbil, Ronald C. Petersen, Clifford R. Jack, Melissa J. Terpstra, David T. Jones

Summary: From a complex systems perspective, clinical syndromes emerging from neurodegenerative diseases are thought to result from multiscale interactions between aggregates of misfolded proteins and the disequilibrium of large-scale networks coordinating functional operations underpinning cognitive phenomena. Age-related disruption of the default mode network is accelerated by amyloid deposition in all syndromic presentations of Alzheimer's disease, while syndromic variability may reflect selective neurodegeneration of modular networks supporting specific cognitive abilities. This study investigates the use of a biomarker of default mode network dysfunction, the network failure quotient, to assess Alzheimer's disease in a normative cohort and differentiate between different phenotypes of the disease. The study provides important insights into the shared pathophysiological mechanisms and distinct neurodegenerative processes involved in Alzheimer's disease.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Neuroimaging, clinical and life course correlates of normal-appearing white matter integrity in 70-year-olds

Sarah-Naomi James, Emily N. Manning, Mathew Storey, Jennifer M. Nicholas, William Coath, Sarah E. Keuss, David M. Cash, Christopher A. Lane, Thomas Parker, Ashvini Keshavan, Sarah M. Buchanan, Aaron Wagen, Mathew Harris, Ian Malone, Kirsty Lu, Louisa P. Needham, Rebecca Street, David Thomas, John Dickson, Heidi Murray-Smith, Andrew Wong, Tamar Freiberger, Sebastian J. Crutch, Nick C. Fox, Marcus Richards, Frederik Barkhof, Carole H. Sudre, Josephine Barnes, Jonathan M. Schott

Summary: This study investigates the associations between normal-appearing white matter microstructural integrity, brain health, cognition, demographics, genetics, and cardiovascular health in cognitively normal adults in their seventies. The results show that measures of brain health, cognition, demographics, genetics, and cardiovascular health are associated with the microstructural integrity of normal-appearing white matter. Additionally, sex, blood pressure, and cardiovascular health in females were found to have an impact on white matter integrity.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Operationalizing the centiloid scale for [18F]florbetapir PET studies on PET/MRI

William Coath, Marc Modat, M. Jorge J. Cardoso, Pawel J. A. Markiewicz, Christopher A. D. Lane, Thomas D. Parker, Ashvini M. Keshavan, Sarah M. E. Buchanan, Sarah E. J. Keuss, Matthew J. Harris, Ninon Burgos, John Dickson, Anna L. Barnes, David L. Thomas, Daniel B. Beasley, Ian B. Malone, Andrew Wong, Kjell A. Erlandsson, Benjamin A. Thomas, Michael Scholl, Sebastien Ourselin, Marcus C. Richards, Nick C. M. Fox, Jonathan M. M. Schott, David M. Cash

Summary: The Centiloid scale aims to harmonize Aβ PET measures across different analysis methods. This study investigated the Centiloid transformation with PET/MRI data, finding that the transformation is valid but further understanding of the effects of acquisition or biological factors on using white matter as a reference is needed.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2023)

Article Clinical Neurology

A practitioner's guide to geospatial analysis in a neuroimaging context

Julie K. K. Wisch, Ganesh M. Babulal, Kalen Petersen, Peter R. R. Millar, Enbal Shacham, Stephen Scroggins, Anna H. H. Boerwinkle, Shaney Flores, Sarah Keefe, Brian A. A. Gordon, John C. C. Morris, Beau M. M. Ances

Summary: This article presents a practical guide for applying geospatial methods to a neuroimaging cohort, aiming to evaluate the impact of the environment on the brain. The authors used structural magnetic resonance imaging data from 239 city-dwelling participants in St. Louis, Missouri, and compared them to population-level estimates from the American Community Survey to identify neighborhoods associated with altered brain structure. They observed a relationship between neighborhoods and brain health, suggesting the potential for neighborhood-based interventions.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2023)

暂无数据